Solution and method for reducing the virulence of viruses, bacteria, yeasts, or fungus
AssigneeDavid Changaris
InventorsDavid G. Changaris, Anne L. Carenbauer
Life of this patent
Estimating the term…
Abstract
A method of reducing the virulence of microbes in or on the human body and a method of sanitizing or disinfecting a surface, area, object, or porous or non porous material is provided. The methods comprise applying or injecting a solution having an effective amount of a conjugated diene for substantially reducing the virulence of the microbes or sanitizing or disinfecting a surface, area, object, or porous or non porous material.
Claims12
A method of reducing the virulence of microbes or the microbes of diseases thereof in a human body comprising:
- applying to the human a solution to at least one of a mouth, the nasal cavities, the lungs, the eyes, or the vagina, or injecting a solution intravenously;
- wherein the applied or injected solution comprises a conjugated diene having a structure of R1-C═C—C═C—R2 in an amount effective for at least a log 2 kill of the microbes or diseases thereof within two minutes of the applying or injecting of the solution;
- wherein the microbes or diseases thereof are selected from the group consisting of Candida auris, Candida albicans, SARS-COV-2, COVID-19, and combinations thereof;
- wherein R1 has between 6 carbons and 9 carbons and an aliphatic chain and R2 has between 4 carbons and 5 carbons, a carbon chain, and a carboxyl group.
A method of sanitizing or disinfecting a solid surface by reducing the virulence of microbes or the microbes of diseases thereof comprising:
- applying an effective amount of a conjugated diene having a structure of R1-C═C—C═C—R2 to the solid surface;
- wherein a solution comprises the effective amount of the conjugated diene for at least a 2 log kill of microbes or diseases thereof within two minutes of the applying of the solution;
- wherein the microbes or diseases thereof are selected from the group consisting of Candida auris, Candida albicans, SARS-COV-2, COVID-19, and combinations thereof;
- and
- wherein R1 has between 6 carbons and 9 carbons and an aliphatic chain and R2 has between 4 carbons and 5 carbons, a carbon chain, and a carboxyl group.
Dependencies are inferred from the claim text.